The Best Tech Stocks to Buy Now On the Dip: CRM for Triple-Digit Upside?

Salesforce is framed as a beaten-down value opportunity, trading at 17.9x forward earnings, more than 50% below its 2024 peak and about 30% below Tech. The article highlights 10% revenue growth last year, Agentforce reaching $800 million in ARR, and management's FY30 revenue target of $63 billion, while noting AI disruption risks and oversold technicals. Overall tone is cautiously constructive, with analysts pointing to about 50% upside to the average price target.

Analysis

The setup is less about whether Salesforce is “cheap” and more about whether AI changes the profit pool faster than the market expects. If agentic workflows reduce the need for seat-based SaaS spend, the first-order loser is CRM, but the second-order winners are the infrastructure and model layers that capture usage-based economics: hyperscalers, model providers, and data/compute vendors. That said, enterprise software rarely gets commoditized overnight; the more likely path is slower module-by-module dilution, which means the market may be discounting a 3-5 year threat into the next 4-6 quarters.

The near-term catalyst path is asymmetric because the stock is already priced for skepticism, so a benign print and stable FY guidance could force shorts and underweights to cover. The key risk is not just revenue slowdown, but margin pressure from AI feature bundling and sales productivity investment, which can make “growth” look intact while free cash flow inflects lower over the next 2-3 reporting cycles. A stronger-than-expected Agentforce adoption read-through would also matter for the broader SaaS complex, because it would suggest AI is monetizing rather than cannibalizing existing workflow software.

Consensus appears to be over-assigning terminal value risk and under-assigning transition optionality. CRM has a credible path to re-rate if investors decide AI is an attachment layer to its installed base rather than a replacement for it, especially since mature software franchises with capital returns tend to get supported when revenue growth stabilizes in the high single digits and buybacks accelerate. The contrarian issue is that if AI adoption remains mainly experimental, the market could keep paying a discount multiple until there is clear proof that attach rates, not just branding, are moving ARR and operating leverage.

Key Decisions for Investors

• Buy CRM on the event: initiate a starter long ahead of earnings only if sizing is kept small; preferred expression is a 3-6 month call spread to define downside while capturing a potential de-rating reversal if guidance holds.
• If already long AI beneficiaries, hedge SaaS exposure by pairing long GOOGL or MSFT against long CRM over the next 1-2 quarters; this isolates the ‘AI monetization vs AI disruption’ debate and reduces factor risk.
• Add on weakness only if CRM sells off post-print on unchanged guidance but no estimate cuts; that would be a sentiment-driven dislocation rather than a fundamental break, with a 6-12 month mean reversion setup.
• Avoid chasing a breakout in CRM if implied volatility collapses after earnings without a material beat; the stock likely needs proof of AI attach-rate economics before sustaining a rerating.
• Watch for a relative-long setup in MSFT vs CRM if enterprise AI spend shifts toward platform consolidation; MSFT is the cleaner beneficiary if CIO budgets prioritize infrastructure over application-layer experimentation.